# BMS Paid $380M to Reserve a Machine That Had Never Treated a Patient - Date: 2026-04-14 - Category: Biotech & Life Sciences Before the first patient was treated on Cellares automated CAR T platform, BMS paid $380M to lock up the manufacturing capacity. That tells you everything. ---